Overview
Case summary
The United States appealed a decision by the board of general appraisers regarding the tariff classification of antitoxin imported by Schulze, Berge & Koechl. The antitoxin, used for diphtheria prevention and cure, was produced from horse blood treated with diphtheria poison. The collector assessed a 25% ad valorem duty under paragraph 59 of the Tariff Act of 1894 as a medicinal preparation not specially provided for. The importers claimed it should be free under paragraph 664 as vaccine virus. The Circuit Court held that antitoxin is distinct from vaccine virus in source, purpose, and operation, and paragraph 664's specific reference to vaccine virus does not extend to antitoxin by implication. Thus, the court reversed the board's decision, affirming the collector's classification.
Abstract
The United States appealed a decision classifying imported antitoxin, produced from horse blood treated with diphtheria poison, as free under the tariff act's vaccine virus provision rather than dutiable as a medicinal preparation. The court held that antitoxin is distinct from vaccine virus in source, purpose, and operation, so the specific reference to vaccine virus does not extend to antitoxin by implication. The decision of the general appraisers was reversed, affirming the collector's classification and duty assessment.
Opinion of the court
opinionWHEELER, District Judge
- Antitoxin differs from vaccine virus in source, purpose, and operation
- Paragraph 664 has well-defined meaning limited to vaccine virus
- No implication extends paragraph 664 to cover antitoxin
Jurisdiction
not challenged- Appeal by government from decision of board of general appraisers
Procedural posture
- Classification of antitoxin under tariff act of 1894
Subsequent history
Legal categories
Case record
Issues & holdings
De novo interpretation of tariff statutes
Antitoxin is different from vaccine virus in source, purpose, and operation, and paragraph 664 does not cover it by implication
Issue preserved for review
Holdings of the court
Statutory interpretation
2Burden of proof
Standards of review
- Interpretation of tariff act classification — de novo Statutory interpretation reviewed de novo
Timeline
Tariff Act of 1894 enacted, including paragraphs 59 and 664
Outcome: Statute passed
Provides legal framework for customs duties classification
Circuit Court reversed decision of general appraisers, holding antitoxin dutiable
Outcome: Reversal of board decision
Final appellate ruling on tariff classification
Importation of antitoxin by Schulze, Berge & Koechl at Port of New York
Outcome: Collector assessed 25% duty as medicinal preparation
Initial classification triggering dispute
Board of general appraisers reversed collector's decision
Outcome: Reversal of collector's classification
Lower court decision appealed by government
Facts & evidence
Incident
Key facts
5 facts- Importation of antitoxin invoiced as 'Blood Serum — Diphtheria Remedy'
- Antitoxin produced from blood of horses treated with diphtheria poison
- Used for prevention and cure of diphtheria
- Collector assessed 25% ad valorem duty as medicinal preparation
- Importers claimed exemption under various tariff paragraphs
Disputed questions
- Whether antitoxin is vaccine virus for tariff purposes
Procedural history
3 steps- Collector classified antitoxin as dutiable medicinal preparation
- Board of general appraisers reversed collector's decision
- Government appealed board decision to Circuit Court
Evidence in the record
- Antitoxin invoiced as 'Blood Serum — Diphtheria Remedy'
- Shown to be agent for prevention and cure of diphtheria produced from horse blood
- Antitoxin substance
- Tariff Act of 1894 paragraphs 59 and 664
- Import invoice
Objects of relevance
Policy considerations
- Clarity in tariff classifications to avoid ambiguity
- Promotion of consistent application of customs laws
Authorities
Statutes
- Tariff Act of 1894, paragraphs 59 and 664
Standards & doctrines
- De novo review of statutory interpretation
Legal principles applied
- Specific statutory terms construed narrowly without implication
Notable quotes
“Antitoxin is a different thing from vaccine virus. It comes from a different source, is used for a different although somewhat similar purpose, and operates in a different way.”WHEELER, District Judge — Comparing antitoxin and vaccine virus for tariff classificationKey reasoning for distinguishing the two substances under the tariff act
“The latter has such a well-defined meaning, applicable to one thing, that, against a first impression, it does not now seem capable of covering, by any implication, such a different thing as the former.”WHEELER, District Judge — Interpreting paragraph 664's reference to vaccine virusEmphasizes strict construction of tariff exemptions